1. Home
  2. GH vs NWS Comparison

GH vs NWS Comparison

Compare GH & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$86.76

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Logo News Corporation Class B

NWS

News Corporation Class B

HOLD

Current Price

$30.46

Market Cap

15.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
NWS
Founded
2011
2012
Country
United States
United States
Employees
N/A
22300
Industry
Medical Specialities
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
15.8B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GH
NWS
Price
$86.76
$30.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
4
Target Price
$119.79
$38.18
AVG Volume (30 Days)
2.0M
862.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.66%
EPS Growth
6.74
N/A
EPS
N/A
N/A
Revenue
$982,021,000.00
N/A
Revenue This Year
$33.30
$6.06
Revenue Next Year
$28.27
$3.25
P/E Ratio
N/A
$12.98
Revenue Growth
32.88
N/A
52 Week Low
$36.36
$25.49
52 Week High
$120.74
$35.58

Technical Indicators

Market Signals
Indicator
GH
NWS
Relative Strength Index (RSI) 46.59 67.29
Support Level $82.33 $29.98
Resistance Level $98.58 $31.27
Average True Range (ATR) 4.64 0.62
MACD -0.12 0.03
Stochastic Oscillator 44.51 85.90

Price Performance

Historical Comparison
GH
NWS

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About NWS News Corporation Class B

News Corporation is a diversified media conglomerate with big presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

Share on Social Networks: